Daniel Wozniak, Ph.D. Professor, Microbial Infection and Immunity, Microbiology Co-director, Microbial Communities Thematic Area Co-director, OSU-NCH Cure CF Columbus (C3) Research Development Program Ohio State University Biosketch: Dr. Daniel Wozniak obtained his Ph.D. in Microbiology from the Ohio State University in 1989. He spent a three-year Cystic Fibrosis Foundation supported fellowship at the University of Tennessee Medical School studying the molecular biology and pathogenesis of Pseudomonas aeruginosa. He joined the faculty of Wake Forest University School of Medicine in 1993 and remained there until 2008, when he returned to Ohio State University. He is currently a full professor in the Departments of Microbial Infection and Immunity and Microbiology. Dr. Wozniak has published ~110 peer-reviewed manuscripts, 5 book chapters, and >225 abstracts/conference proceedings. He currently has twelve scientists in his group. Each is studying some aspect of bacterial pathogenesis, biofilm biology, or therapeutics. Dr. Wozniak's research activities are focused on the pathogenesis of bacteria that cause chronic, devastating infections in humans including Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter. These bacteria exhibit a biofilm-mode of growth rendering them resistant to antimicrobials and phagocytic cells. Dr. Wozniak also brings expertise in pathogenesis and therapeutics of chronic wound infections. Dr. Wozniak has NIH- and CFF- sponsored research to study biofilm matrix composition and function, immune interactions with biofilms, pathoadaptation, therapeutics, and chronic infections.